Rash isn’t the most common symptom of Hodgkin lymphoma, but oncologists say it can happen. “This is often a rash that will ...

A new discovery made by researchers from The Australian National University (ANU) could lead to smarter, more effective ...

A multidrug regimen containing brentuximab vedotin (BV, Adcetris) proved feasible for older patients with advanced classical ...

Original Article Published: 01 October 2000 CD44H and CD44V6 Expression in Different Subtypes of Hodgkin Lymphoma Faten Anwar M.D. & Brent L Wood M.D., Ph.D. Modern Pathology 13, 1121–1127 (2000 ...

Background: BR was previously reported to be statistically noninferior to R-CVP/R-CHOP for complete response rate in the treatment of patients with indolent NHL or MCL. Evaluation of time-to-event ...

This review offers an in-depth exploration of Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL), highlighting its distinct characteristics across various domains such as epidemiology ...